Esquerdo, Gaspar <br/><br/>
Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy.  [electronic resource] 

 -  Tumori   
 - 225-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2038-2529 
<br/><br/><label>Standard No.: </label>10.1177/030089161410000218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anemia--blood<br/>Antineoplastic Agents--administration & dosage<br/>Darbepoetin alfa<br/>Drug Administration Schedule<br/>Erythropoietin--administration & dosage<br/>Fatigue--etiology<br/>Female<br/>Follow-Up Studies<br/>Hematinics--administration & dosage<br/>Hemoglobins--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Prospective Studies<br/>Quality of Life<br/>Treatment Outcome